S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS

• P Delaporta,
• D Kyriakopoulou,
• N Ioakeimidou,
• E Solomou,
• I Binenbaum,
• K Toutoudaki,
• M Chatzielefteriou,
• I Papassotiriou,
• A Kattamis

Affiliations

P Delaporta

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

D Kyriakopoulou

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

N Ioakeimidou

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

E Solomou

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

I Binenbaum

2 Pediatric Hematology Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia, Athens, GREECE

K Toutoudaki

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

M Chatzielefteriou

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE

I Papassotiriou

3 Department of Clinical Biochemistry, Athens, GREECE

A Kattamis

1 First Department of Pediatrics, National and Kapodistrian University of Athens, ‘Aghia Sophia’ Children’s Hospital, Athens, GREECE